Nuklearmedizin 2020; 59(03): 276-280
DOI: 10.1055/a-1152-2341

Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19

Nuklearmedizin zu Zeiten der SARS-CoV-2 Pandemie: 18F-FDG-PET/CT zur Visualisierung von COVID-19
Susanne Lütje
1   Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
Milka Marinova
2   Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany
Daniel Kütting
2   Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany
Ulrike Attenberger
2   Clinic for Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany
Markus Essler
1   Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
Ralph Alexander Bundschuh
1   Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany
› Author Affiliations


The current outbreak of coronavirus SARS-CoV-2 has reached multiple countries worldwide. While the number of newly diagnosed cases and fatalities is rising quickly, far-reaching measures were enacted to prevent further spread. Diagnosis relies on clinical presentation, exposure history, PCR using specimens from the respiratory tract together with computed tomography (CT) imaging. One of the hallmarks of a critical course of COVID-19 is the development of severe acute respiratory distress syndrome (ARDS). As management of COVID-19 can be considered a multi-disciplinary approach involving various medical specialties, we here review the first 18F-FDG-PET/CT scans of COVID-19 to discuss how Nuclear Medicine could contribute to management of this disease.


Der Ausbruch des Coronavirus SARS-CoV-2 hat inzwischen viele Länder weltweit erreicht. Trotz weitreichender Maßnahmen zur Eindämmung der Ausbreitung steigen die Fallzahlen kontinuierlich weiter. Die Diagnose der durch SARS-CoV-2 hervorgerufenen COVID-19 Erkrankung erfolgt mittels Polymerasekettenreaktion aus Proben des Respirationstrakts und computertomographischer Bildgebung der Lunge. Die Erkrankung kann asymptomatisch oder mild verlaufen und sich mit Fieber oder trockenem Husten manifestieren. Eine gefürchtete schwere Verlaufsform von COVID-19 ist die Entwicklung eines ARDS (acute respiratory distress syndrome). Da insbesondere schwere Krankheitsverläufe oftmals eine multidisziplinäre Vorgehensweise erfordern, besprechen wir hier anhand einiger 18F-FDG-PET/CT Fallbeispiele, welche Rolle die Nuklearmedizin bei COVID-19 einnehmen könnte.

Publication History

Received: 03 April 2020

Accepted: 03 April 2020

Article published online:
07 April 2020

© Georg Thieme Verlag KG
Stuttgart · New York

  • References

  • 1 Zhu N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
  • 2 Huang C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
  • 3 Thomas-Ruddel D. et al Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist 2020; DOI: 10.1007/s00101-020-00760-3. [Epub ahead of print]
  • 4 Chung M. et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020; 295 (01) 202-207
  • 5 Salehi S. et al Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol 2020; 1-7 DOI: 10.2214/AJR.20.23034. [Epub ahead of print]
  • 6 Hosseiny M. et al Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. AJR Am J Roentgenol 2020; 1-5 DOI: 10.2214/AJR.20.22969. [Epub ahead of print]
  • 7 Bernheim A. et al Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020; 200463 DOI: 10.1148/radiol.2020200463. [Epub ahead of print]
  • 8 Koo HJ. et al. Radiographic and CT Features of Viral Pneumonia. Radiographics 2018; 38 (03) 719-739
  • 9 Capitanio S. et al. PET/CT in nononcological lung diseases: current applications and future perspectives. Eur Respir Rev 2016; 25 (141) 247-258
  • 10 Qin C. et al. (18)F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging 2020; 47 (05) 1281-1286
  • 11 Zou S, Zhu X. FDG PET/CT of COVID-19. Radiology 2020; 200770 DOI: 10.1148/radiol.2020200770. [Epub ahead of print] No abstract available
  • 12 Czernin J. et al Imaging clinic operations in the times of COVID-19: Strategies, Precautions and Experiences. J Nucl Med 2020
  • 13 Das KM. et al. Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?. Am J Roentgenol 2016; 206 (06) 1193-1201
  • 14 Chefer S. et al. Modeling [(18)F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge. EJNMMI Res 2015; 5 (01) 65
  • 15 Wilks M. et al. In vivo PET Imaging of Monocyte/Macrophage Inflammation in Non-Human Primates. J Nucl Med 2019; 60 (Suppl. 01) 408
  • 16 Wallace M. et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. Virology 2000; 274 (02) 255-261
  • 17 Gao QY, Chen YX, Fang JY. 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis 2020; DOI: 10.1111/1751-2980.12851. [Epub ahead of print] No abstract available
  • 18 Thackeray JT. et al. Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. J Am Coll Cardiol 2018; 71(3): 263-275
  • 19 Bellani G. et al. Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT study. Crit Care Med 2009; 37 (07) 2216-2222
  • 20 Rodrigues RS. et al. FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report. Intensive Care Med 2008; 34 (12) 2273-2278